Intravenous iron and erythropoiesis-stimulating agents in haemodialysis: A systematic review and meta-analysis.

Nephrology (Carlton) · 2017 · PMC5725690 · PMID 27699922

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

A comparison of intravenous iron versus oral iron/no iron (five trials) showed a greater reduction in ESA dose, although this did not reach statistical significance (weighted mean difference, 95% CI: −2,433 [−5183, 318] units/week).

also in 111,027 other papers

did not achieve significanceno p-value reported

There were fewer patients who reported adverse effects with IV iron, but the result did not achieve significance: (12 studies, 1488 patients; risk difference −0.09, 95% CI 0.19 to 0.00; I 2 = 85%).

also in 1,397 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.